01

SCROLL DOWN

ABOUT US

RENHAIM Therapeutics Inc. is a strategic R&D
company aiming at the Bench-to-Market of gene-based pharmaceuticals.

All processes, from research to clinical development
and licensing,
require the integration of highly specialized technology, which is a heavy burden
for a bio business because it is often insufficient in terms of resources and technical,
human, and material knowledge to act competently.

Therefore, RENHAIM Therapeutics, Inc. intends to develop biopharmaceutical
products efficiently through open innovation with R&D specialists.

READ MORE

RENHAIM R&D

mRNA Platform
Cancer Vaccine
Therapeutics
상단이동버튼